Evidence map›Paper›PMID 31632520›Full record

ArticleAmerican journal of translational research2019

Effect of local application of biphosphonates on improving peri-implant osseointegration in type-2 diabetic osteoporosis.

Xiaoqian Ding, Lan Yang, Yun Hu, Jinfeng Yu, Yu Tang, Dan Luo, Leilei Zheng

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. [Zoledronate regulates osteoclast differentiation and bone resorption in high glucose through p38 MAPK pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaoqian DingCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Lan YangCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Yun HuCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Jinfeng YuCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Yu TangCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Dan LuoCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Leilei ZhengCollege of Stomatology, Chongqing Medical University Chongqing 401147, China.
Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM), a leading cause of osteoporosis, remains a contraindication for bone implant therapy. Although associated with side effects when systemically administered, biphosphonates (BPs) play a positive role in diabetic osteoporosis treatment. We hypothesized that local BP therapy would prevent decayed implant osseointegration under T2DM conditions. To assess cell proliferation and determine the optimal BP concentration, bone marrow-derived mesenchymal stem cells (BMSCs) and bone marrow macrophages (BMMs) were treated with BPs at various relatively low concentrations (10

Indexed as

bisphosphonatesimplantosseointegrationOsteoporosistype 2 diabetes mellitus

Identifiers

PMID31632520
PMCPMC6789268
OpenAlexW2990508316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.